KemPharm, Inc. (KMPH) CEO Travis Mickle on Q2 2022 Results - Earnings Call Transcript

SA Transcripts
154.53K Followers

KemPharm, Inc. (KMPH) Q2 2022 Earnings Conference Call August 11, 2022 5:00 PM ET

Company Participants

Nichol Ochsner - Vice President-Investor Relations & Corporate Communications
Travis Mickle - President & Chief Executive Officer
Perry Sternberg - Chief Executive Officer, Corium Inc.
LaDuane Clifton - Chief Financial Officer

Conference Call Participants

Jonathan Aschoff - ROTH Capital Partners

Operator

Good afternoon, and welcome to the KemPharm Second Quarter 2020 Corporate and Financial Results Conference Call. Currently, all callers have been placed in a listen-only mode and following managements prepared remarks, the call will be opened up for questions. [Operator Instructions] Please be advised that today's call is being recorded.

I will now turn the call over to Nichol Ochsner, KemPharm’s Vice President, Investor Relations and Corporate Communications. Thank you. Ma'am, you may begin.

Nichol Ochsner

Thank you. Good afternoon, and thank you for joining our call to discuss KemPharm's second quarter 2022 financial and corporate results.

Before we begin, I would like to remind our listeners that remarks made during this call may contain forward-looking statements that involve risks and uncertainties and are subject to changes at any time, including but not limited to, statements about KemPharm's expectations regarding future operating results. Forward-looking statements are made pursuant to the safe harbor provisions of the federal securities laws and represent management's current expectations. Actual results may differ materially.

KemPharm disclaims any obligation to update or revise forward-looking statements except as required by law. For more information regarding forward-looking statements, risks and uncertainties can be found in KemPharm's filings with the SEC, which are available on KemPharm's website under the Investor Relations section.

Speaking on today's call will be Travis Mickle, KemPharm's President and CEO; and LaDuane Clifton, CFO. In addition, we are very pleased to have Perry Sternberg President and CEO of Corium Inc. on today's call to provide

Recommended For You

About ZVRA Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on ZVRA